Keeping Cancer Patients' Bones Strong (IMAGE)
Caption
An experimental anti-cancer drug also prevented the severe bone-loss that normally accompanies the disease. This material relates to a paper that appeared in the Ja. 25, 2017, issue of Science Translational Medicine, published by AAAS. The paper, by K. Andrade at University of Utah School of Medicine in Salt Lake City, UT, and colleagues was titled, 'RON kinase: A target for treatment of cancer-induced bone destruction and osteoporosis.'
Credit
K. Andrade <i>et al., Science Translational Medicine</i> (2017)
Usage Restrictions
Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.
License
Licensed content